Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs
Bharat Serums and Vaccines Limited (BSV), a fully-owned subsidiary of Mankind Pharma Limited, has pledged 39.68 per cent of its equity stake to secure non-convertible debentures (NCDs) worth ₹5,000 crores. As the common security trustee for these NCDs, Catalyst Trusteeship Limited was designated by SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015. The share price […]
Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs Read More »